FOLH1 and prostate carcinoma: In a multicenter retrospective analysis, Grüning et al. investigated the commonly observed unspecific bone uptake in [18F]F-PSMA-1007 PET/CT scans of 348 prostate cancer patients and found that UBU was present in 51% of patients.